The natural history of chronic HBV infection and geographical differences.
about
Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCsCharacteristics of Hepatitis B Co-infection and Disease Evolution in HIV-Positive Paediatric Patients in RomaniaNatural history of chronic hepatitis B: phases in a complex relationship.Investigation into the effect of hepatitis B virus on apoliprotein A1 expression and its mechanismComparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.High prevalence of hepatitis B virus genotype C/C1 in the Minangkabau ethnic group in Indonesia.Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster doseIs hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapyClinical relevance of hepatitis B virus variantsHBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients.Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune CellsCorrelations between ASCC3 Gene Polymorphisms and Chronic Hepatitis B in a Chinese Han Population.Assessment of knowledge, attitudes and practices toward prevention of hepatitis B virus infection among students of medicine and health sciences in Northwest EthiopiaKASL Clinical Practice Guidelines: Management of chronic hepatitis B.Hepatitis B virus burden in developing countries.Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study.A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.Patients with hematological malignancies and serological signs of prior resolved hepatitis B.Experimental models and therapeutic approaches for HBV.Re-appraisal of old and new diagnostic tools in the current management of chronic hepatitis B.Immunopathogenesis of chronic hepatitis B.Prevention of hepatitis B virus infection: from the past to the future.Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.New Anti-HBV C-Boivinopyranosyl Flavones from Alternanthera philoxeroides.Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains.Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.Alanine aminotransferase course, serum hepatitis B virus DNA, and liver stiffness measurement for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B.A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation.Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B.Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation.Anti-HBs seroconversion during treatment with entecavir in a patient with chronic hepatitis B virus infection on hemodialysis.Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients.Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection.The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.
P2860
Q28086980-92B7EA46-C6BA-46FC-9651-CAF6639E382BQ33973843-346BC0BD-E7B2-4A89-95B8-D0CEFFA9B360Q34036650-0A84B58C-8D7B-4037-823A-BE699BEEF792Q34135965-F727ED40-9E3E-4AAC-8EBB-AD2906F00586Q34489239-C5F0404F-C26D-460E-974C-A944D868E57FQ34556305-377C5858-1341-4ED5-8A72-F48BFA661C9DQ34637622-3C9321DC-09A9-4BA5-B03A-B1300E036575Q35501225-3DC84816-73F9-4E29-A456-E6898D04EACBQ35668730-B930AD74-F13B-4A5D-8BB3-40E25DFF7446Q35706571-A2AC4554-4691-43E5-B4F9-C13DB1EFCF4CQ35758694-C33B06F9-5EA5-40E4-A0FC-5EE6CE704C59Q35832306-2C081595-35CF-4094-9184-88E6BDEBBCC8Q36108309-420A7116-E9DF-48C7-B511-2C9D51EBA04DQ36153966-9CE627D2-95C0-4369-B39B-8C1697C5A810Q36269649-7B459205-007B-4C4D-821A-3CBE28C0D577Q36474957-E15AC1D3-71CF-4231-B4F2-026C34C6BCB3Q36958950-C9371371-C4A7-4A65-B575-DB5907674D0FQ37710785-9186271E-4117-424B-93B7-00010AE9F8F1Q37964712-7313ACD7-BB08-4C0D-9233-5C1817AAC301Q37999022-8CD4D7AF-1DE8-4A28-8DAE-493A8CB3BFAAQ38035173-28E57980-3D08-457A-9B18-76214558E9A7Q38237418-9F08C397-0D71-4BB8-9EAB-89D3AC749A0FQ38262108-3B0BB81B-7C61-40E2-BD11-7DC26D04C475Q38354222-9CAD4D34-9F17-44A0-AD7B-656A7B68720FQ38408847-D153ECEA-8BCB-434A-8112-6011ABEA28BFQ38785600-2BA0DC25-53DD-42F4-99B0-2B20E470EDDAQ39213627-6F3E951C-88EA-4583-86E7-576CCF85AF72Q40185369-3FA48446-F9C6-4AF8-9C43-25D66CC1A547Q40291383-1EC6B10D-C028-4639-8285-867648693ED4Q40869919-C97240B5-F91D-4A0E-BAA6-70FA08763339Q41070767-4AE70B41-4949-4084-92B5-D436D4DB5DD9Q41927506-693A2290-51B5-4821-A105-B981A81B59FCQ42217926-055CF5BC-9344-4E26-A0BE-CD704B1A677DQ42232110-415B0A28-9C42-4502-9A37-8B0D540DD21DQ42258017-BF2D5362-A4EB-43DC-B9EB-87F6526E09C6Q42261578-AEA2BE2D-A54A-41A5-883C-5BBF54E46C6BQ42263068-73913CAC-6B88-4DA9-8E5B-6A4F61268AEAQ44047772-C464B6D2-1DCB-488B-B231-EDF987D6109EQ44725549-BAE6C24C-4D9C-428D-84B8-0A5353CE0F17Q47242836-F9187DF9-1D47-4331-B7AD-357F9EDDD334
P2860
The natural history of chronic HBV infection and geographical differences.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The natural history of chronic HBV infection and geographical differences.
@ast
The natural history of chronic HBV infection and geographical differences.
@en
The natural history of chronic HBV infection and geographical differences.
@nl
type
label
The natural history of chronic HBV infection and geographical differences.
@ast
The natural history of chronic HBV infection and geographical differences.
@en
The natural history of chronic HBV infection and geographical differences.
@nl
prefLabel
The natural history of chronic HBV infection and geographical differences.
@ast
The natural history of chronic HBV infection and geographical differences.
@en
The natural history of chronic HBV infection and geographical differences.
@nl
P356
P1433
P1476
The natural history of chronic HBV infection and geographical differences.
@en
P2093
Stephanos Hadziyannis
P356
10.3851/IMP1621
P478
15 Suppl 3
P577
2010-01-01T00:00:00Z